CClinicalTrials.gg
CompletedNCT03891563PREVIEWUpdated Oct 7, 2026

Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip

An observational study in Femoroacetabular Impingement, sponsored by McMaster University. Completed at 4 sites in 3 countries. Open to participants aged 12 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by McMaster University · Observational

Updated Oct 7, 2026Now CompletedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
201
Ages
12 Years to 14 Years
Sex
All
01

Study summary

Femoroacetabular impingement (FAI) is a condition of the hip where there is a mis-fit between the femoral head (ball) and hip acetabulum (socket). The abnormalities on the hip bones collide or "impinge" during movements such as hip flexion and rotation. Typically, patients with this condition are young adults who present with hip pain, loss of hip function, and in many cases, osteoarthritis later in life. The rate of diagnoses of FAI has dramatically risen across all age groups, but it has been especially notable within adolescent populations. There has been a corresponding increase in the number of surgeries performed on younger and younger hips to treat pain and loss of function due to this condition. Preliminary small-scale research has hypothesized that increased activity, such as sport specialization (i.e. playing only one sport for most of the year) at an early age when the hip is still developing, may be the cause. In the past 20 years, sport injuries among children have dramatically increased, where close to 45 million young athletes participate in organized sports annually in Canada and the US alone. There is a current trend among coaches and parents to have children focus on one sport with the thought that this dedication will allow them to reach an elite level. We are proposing the first international, longitudinal cohort study to determine the effect of sport specialization on the development of FAI during the critical phase of hip development (i.e. between the ages of 12-14 years). Volunteer participants will be recruited across Canada and internationally and will be evaluated clinically and radiographically (i.e. using MRI) over 2 years. This study will not only prospectively evaluate the role of sport activity the development of FAI, but also inform preventative training protocols to potentially reduce its incidence among adolescents, and later as adults, as well as identify parameters to detect hips that are at risk for developing FAI.

Read the detailed description

This is a multi-centre, international longitudinal cohort study evaluating 200 participants between the ages of 12-14 that include sport specialists at the moderate to vigorous physical activity (MVPA) level and non-sport specialists at any activity level. Participant groups will be defined according to the AOSSM and AMSSM early sport specialization criteria (2016). We will monitor physical activity levels of all participants using an activity log and a wrist-mounted activity tracker, with synced data collected every 3 months during the study period. In addition, participants will be evaluated clinically and radiographically at time of enrollment and 6, 12, 18, and 24 months. The primary study outcome is the incidence of FAI between groups at 2 years, determined via MRI. Secondary outcomes include hip function and health-related quality of life between subjects diagnosed with FAI versus no FAI at 2 years, as determined by the HOS and PedsQL questionnaires.

02

Conditions studied

  • Femoroacetabular Impingement
03

In context

Femoracetabular Impingement

108 studies on the registry are indexed under Femoracetabular Impingement; 35 are open to participants now.

This study's enrollment of 201 is above the median of 89 across 36 observational studies indexed under Femoracetabular Impingement.

Browse Femoracetabular Impingement studies →

Lead sponsor

McMaster University is the lead sponsor of 720 studies on the registry; 124 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will be comprised of adolescents aged 12-14 with no prior or ongoing hip comorbidities, and consent to receiving MRI scans at baseline and 2 years.

Inclusion criteria

  1. asymptomatic males and females between the ages of 12-14 years
  2. ability to speak, understand, and read the language of the clinical site
  3. provision of informed child assent (if applicable) and parental consent.

Exclusion criteria

Exclusion Criteria:

  1. hip is mature (i.e. closed physes) based on the baseline MRI scan
  2. hip complaints or pain in the hip
  3. previous trauma to the hip
  4. previous surgery on the hip
  5. significant medical co-morbidities (requiring daily assistance for ADLs)
  6. history of or ongoing paediatric hip disease (Legg-Calve-Perthes; slipped capital femoral epiphysis, hip dysplasia)
  7. participants that have contraindications and/or are unwilling to undergo an MRI (e.g. claustrophobia)
  8. participants who will likely have problems, in the judgment of the investigator, with maintaining follow-up
  9. any other reasons the investigator feels is relevant for excluding the subject.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
201 participants (actual)
Patient registry
No

Groups and cohorts

  • Sport specialists, MVPA

    AOSSM Criteria: 1. Participation in intensive training and/or competition in organized sports greater than 8 months per year (essentially year round) 2. Participation in 1 sport to the exclusion of participation in other sports (limited free play overall) 3. Involving prepubertal (seventh grade or roughly age 12 years) children. AND Activity Tracker Criteria: Greater than 180 accumulated minutes of moderate-to-vigorous physical activity (MVPA) during participation in one sport type across one week of activity tracking \- Meets these criteria within either one or both years of follow-up

  • Non-sport specialist, any activity level

    AOSSM Criteria: 1. Participation in more than 1 sport at any physical activity level OR 2. Participation in none or low training and/or competition in organized sports for any period of time. 3. Involving prepubertal children. AND Activity Tracker Criteria: Greater than or less than 180 accumulated minutes of MVPA across one week of activity tracking \- Meets these criteria during both years of follow-up

06

What researchers measure

Primary outcomes

  1. Incidence of radiographic FAI

    The primary outcome is the incidence of radiographic FAI between groups at 2 years, as determined by the dedicated MRI of the hip. We will identify both symptomatic and asymptomatic cases, where asymptomatic FAI can become symptomatic in young adulthood, and/or could be associated with idiopathic osteoarthritis later in life.

    Time frame: 2 years

Secondary outcomes

  1. Hip function

    As determined by the Hip Outcome Score

    Time frame: 2 years

  2. Health-related quality of life

    As determined by the Pediatric Quality of Life questionnaire

    Time frame: 2 years

07

Study locations

4 sites
  • McMaster University
    Hamilton, Ontario L8N3Z5, Canada
  • Chu du Quebec
    Québec, Quebec G1J1Z4, Canada
  • Erasmus Medical Centre
    Rotterdam, Netherlands
  • Kyungpook National University Hospital
    Daegu, Gyeongsangbuk-do 41944, South Korea
08

References and documents

Publications

  • Ohlin A, Simunovic N, Duong A, Ayeni OR; PREVIEW investigators. Protocol for a multicenter prospective cohort study evaluating sport activity and development of femoroacetabular impingement in the adolescent hip. BMC Musculoskelet Disord. 2020 Apr 11;21(1):221. doi: 10.1186/s12891-020-03220-6. PubMed 32278355 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Status
Active, not recruiting→Completed
changed Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Active, not recruiting→Completed
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03891563
Lead sponsor
McMaster University
Collaborators
McMaster Surgical Association, Arthroscopy Association of North America, Conmed, Canadian Institutes of Health Research (CIHR)
Responsible party
Sponsor
First posted
Mar 27, 2019
Start date
Oct 18, 2017
Primary completion
Jul 31, 2025
Completion
Dec 31, 2025
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion